A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: Long-term experience with etoposide and thiotepa

Bone Marrow Transplantation

Volumn 33, Issue 1, 2004, Pages 19-24

  McCoy, A G ^a,b   Smith, E P ^a   Atkinson, M E ^a   Baranski, B ^a   Kahl, B S ^a   Juckett, M ^a   Mitchell, T ^a   Gangnon, R ^a   Longo, W L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NONE   (United States)

Author keywords

Autologous transplant; Non Hodgkin's lymphoma; Preparative regimen

Indexed keywords

ANTIEMETIC AGENT; BENZODIAZEPINE DERIVATIVE; BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; OPIATE; THIOTEPA; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLADDER CARCINOMA; BRAIN HEMORRHAGE; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CONFIDENCE INTERVAL; CONFUSION; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG INDUCED CANCER; DRUG INFUSION; DRUG PENETRATION; DRUG RESISTANCE; DRUG SENSITIVITY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEART LEFT VENTRICLE FAILURE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPERBILIRUBINEMIA; INFECTION; ISCHEMIC HEART DISEASE; LARGE CELL LYMPHOMA; LIVER DYSFUNCTION; LIVER HEMORRHAGE; LIVER VENOOCCLUSIVE DISEASE; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MYCOSIS; NAUSEA; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PNEUMONIA; PRIORITY JOURNAL; STOMATITIS; TRANSITIONAL CELL CARCINOMA; VOMITING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; GASTROINTESTINAL DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL ANALYSIS; THIOTEPA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0742289454     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704312     Document Type: Article

References (15)

1. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540-1545 (see comments).
2. van Besien K, Tabocoff J, Rodriguez M et al. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. Bone Marrow Transplant 1995; 15: 549-555.
3. Patti C, Majolino I, Scime R et al. High-dose cyclophosphamide, etoposide and BCNU (CVB) with autologous stem cell rescue in malignant lymphomas. Eur J Haematol 1993; 51: 18-24.
4. Stiff PJ, Dahlberg S, Forman SJ et al. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens - a Southwest Oncology Group trial. J Clin Oncol 1998; 16: 48-55.
5. Mills W, Chopra R, McMillan A et al. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol 1995; 13: 588-595.
6. Blume KG, Forman SJ. High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies. Semin Oncol 1992; 19: 63-66.
7. Finlay JL, August C, Packer R et al. High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence. J Neurooncol 1990; 9: 239-248.
8. Heideman RL, Cole DE, Balis F et al. Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa. Cancer Res 1989; 49: 736-741.
9. Forman SJ, Blume KG, Thomas ED. Hematopoietic cell transplantation. Blackwell Science: Oxford: Malden MA, USA, 1999, p 947.
10. Alessandrino EP, Bernasconi P, Colombo A et al. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Bone Marrow Transplant 2000; 25: 309-313.
11. Herzig RH. High-dose etoposide and marrow transplantation. Cancer 1991; 67: 292-298.
12. de Magalhaes-Silverman M, Lister J, Rybka W et al. Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma. Bone Marrow Transplant 1997; 19: 777-781.
13. Metayer C, Curtis RE, Vose J et al. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood 2003; 101: 2015-2023.
14. Vose JM, Zhang MJ, Rowlings PA et al. Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 2001; 19: 406-413.
15. Caballero MD, Rubio V, Rifon J et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant 1997; 20: 451-458.